RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Md Nurunnabi to Doxorubicin

Back to Details
This is a "connection" page, showing publications Md Nurunnabi has written about Doxorubicin.
Md Nurunnabi
Connection Strength
0.364
Doxorubicin
  1. Afrin H, Huda MN, Islam T, Oropeza BP, Alvidrez E, Abir MI, Boland T, Turbay D, Nurunnabi M. Detection of Anticancer Drug-Induced Cardiotoxicity Using VCAM1-Targeted Nanoprobes. ACS Appl Mater Interfaces. 2022 Aug 24; 14(33):37566-37576.
    View in: PubMed
    Score: 0.204
  2. Khatun Z, Nurunnabi M, Nafiujjaman M, Reeck GR, Khan HA, Cho KJ, Lee YK. A hyaluronic acid nanogel for photo-chemo theranostics of lung cancer with simultaneous light-responsive controlled release of doxorubicin. Nanoscale. 2015 Jun 28; 7(24):10680-9.
    View in: PubMed
    Score: 0.124
  3. Khatun Z, Choi YS, Kim YG, Yoon K, Nurunnabi M, Li L, Lee E, Kang HC, Huh KM. Bioreducible Poly(ethylene glycol)-Triphenylphosphonium Conjugate as a Bioactivable Mitochondria-Targeting Nanocarrier. Biomacromolecules. 2017 04 10; 18(4):1074-1085.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support